Stephen M. Hahn
CIK: 0002137706
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FTH
Sensei Biotherapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Hahn Stephen M.
Hahn Stephen M. (SEC CIK 0002137706) files insider reports with the SEC as Director of Sensei Biotherapeutics, Inc. (FTH).
Signal8 holds 2 ownership filings by Hahn Stephen M. (1 Form 3, 1 Form 4), filed on Jun 16, 2026. Those filings report 2 transactions, from Jun 12, 2026 to Jun 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hahn Stephen M.'s filings is in AUSTIN, TX.
Recent filings by Hahn Stephen M.
Other insiders filing for Sensei Biotherapeutics, Inc. (FTH)
- Schayowitz Adam, Director
- Vousden Karen H, Director
- Khosla Ventures VI, L.P., 10% Owner
- Craver Josiah, PAO
- Parikh Anand Kiran, President and CEO
- STEPHENSON BRIAN C, Chief Financial Officer